You are being forwarded to your requested URL of https://www.cooley.com/news/coverage/2024/2024-01-02-allorion-therapeutics-announces-exclusive-option-global-license-agreement-with-astrazeneca?utm_source=mondaq&utm_medium=syndication&utm_content=sourceoriginal&utm_campaign=